On the need for an international effort to capture, share and use crystallization screening data by Newman, Janet et al.
scientific comment
Acta Cryst. (2012). F68, 253–258 doi:10.1107/S1744309112002618 253
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
On the need for an international effort to capture,
share and use crystallization screening data
Janet Newman,
a* Evan E.
Bolton,
b Jochen Mu ¨ller-
Dieckmann,
c Vincent J. Fazio,
a
D. Travis Gallagher,
d David
Lovell,
e Joseph R. Luft,
f,g
Thomas S. Peat,
a David
Ratcliffe,
e Roger A. Sayle,
h
Edward H. Snell,
f,g Kerry Taylor,
e
Pascal Vallotton,
i Sameer
Velanker
j and Frank von Delft
k
aMaterials Science and Engineering, CSIRO, 343
Royal Parade, Parkville, VIC 3052, Australia,
bNCBI, NLM, NIH, Department of Health and
Human Services, 8600 Rockville Pike, Bethesda,
MD 20894, USA,
cEMBL Hamburg Outstation
c/o DESY, Notkestrasse 85, D-22603 Hamburg,
Germany,
dNational Institute for Standards and
Technology, 9600 Gudelsky Drive, Rockville,
MD 20850, USA,
eCSIRO ICT Centre and CSIRO
Mathematics, Informatics and Statistics, CS and
IT Building 108, North Road, Australian
National University, GPO Box 664, Canberra,
ACT 2601, Australia,
fHauptman–Woodward
Medical Research Institute, 700 Ellicott Street,
Buffalo, NY 14203, USA,
gSUNY Buffalo
Department of Structural and Computational
Biology, 700 Ellicott Street, Buffalo, NY 14203,
USA,
hNextMove Software, Innovation Center,
Science Park, Milton Road, Cambridge CB4
0EY, England,
iCSIRO Mathematics, Informatics
and Statistics – North Ryde, Building E6B,
Macquarie University Campus, North Ryde,
NSW 1670, Australia,
jEMBL Outstation
Hinxton, European Bioinformatics Institute,
Wellcome Trust Genome Campus, Hinxton,
Cambridge CB10 1SD, England, and
kStructural
Genomics Consortium, Oxford University, Old
Road Campus Research Building, Old Road
Campus, Roosevelt Drive, Oxford OX3 7DQ,
England
Correspondence e-mail:
janet.newman@csiro.au
Received 3 October 2011
Accepted 20 January 2012
When crystallization screening is conducted many outcomes are observed but
typically the only trial recorded in the literature is the condition that yielded the
crystal(s) used for subsequent diffraction studies. The initial hit that was
optimized and the results of all the other trials are lost. These missing results
contain information that would be useful for an improved generalunderstanding
of crystallization. This paper provides a report of a crystallization data exchange
(XDX) workshop organized by several international large-scale crystallization
screening laboratories to discuss how this information may be captured and
utilized. A group that administers a signiﬁcant fraction of the world’s
crystallization screening results was convened, together with chemical and
structural data informaticians and computational scientists who specialize in
creating and analysing large disparate data sets. The development of a
crystallization ontology for the crystallization community was proposed. This
paper (by the attendees of the workshop) provides the thoughts and rationale
leading to this conclusion. This is brought to the attention of the wider audience
of crystallographers so that they are aware of these early efforts and can
contribute to the process going forward.
1. Introduction
‘Those who cannot remember the past are condemned to repeat it’
(Santayana, 1905).
Macromolecular crystallography has been extraordinarily productive
as judged by the exponential growth of the database of structures, the
Protein Data Bank (PDB; Berman et al., 2007). That it has been
judged to be a worthwhile pursuit for over half a century is shown by
the continued support it receives from funding agencies around the
world, by the almost universal demand for its results within the
biochemical and molecular biology communities and by the prizes
awarded to its practitioners, which include 11 Nobel Prizes.
The single most important requirement for structural experiments
of this kind is the availability of appropriate crystals of the macro-
molecule of interest. This is as true now as when the ﬁrst macro-
molecular structure was determined. Clearly, the impressive number
of results captured by the PDB would not be possible if crystallization
of macromolecules were impossible. But the quest for macro-
molecular crystals is currently a trial-and-error enterprise and it is
perhaps surprising that so much structural biology has resulted from
this approach to crystallization.
The concept of making crystallization more robust through the
application of statistical tools was ﬁrst published in 1979, in a seminal
paper describing the use of factorial designs in a crystallization
campaign (Carter & Carter, 1979). This paper has been widely cited,
but the rigorous incomplete factorial methodology described in the
paper has not been widely adopted by the crystallization community.
The reasons can be found in the minutiae of the experiment describedover three decades ago by Carter and Carter. The mathematics of
incomplete design aren’t sensitive to the realities of a crystallization
experiment: some crystallization factors are intrinsically coupled (pH
and buffering species), and some combinations of independent
factors are insoluble (Carter and Carter report that the combination
of Mg
2+ as a cation and PO4
3 as an anion stymied their analyses).
Only six factor classes were used in their work (precipitant, anion,
cation, divalent, temperature and pH) each with a very limited subset
of factors. Furthermore, the methodology demanded that a ranked
value is assigned to the result of each trial. Putting this all together,
the Carter and Carter experiment was simply too difﬁcult to be
widely adopted. And yet the concept of rational exploration of
crystallization space that is so well described in this paper continues
to resonate within the community.
An even more widely cited paper (Jancarik & Kim, 1991) used the
1979 methodology as a springboard for creating a sparse matrix of
crystallization conditions from a set of positive crystallization factors
obtained from the literature. The sparse matrix was developed by
trial and error, rather than through rigorous statistical balancing of
the experiments, but overcame the problems of trying to ﬁt pure
statistics into the messy world of a working laboratory. The Jancarik
and Kim paper revolutionized crystallization. The sparse matrix of
crystallization conditions that they described was trivial to set up, and
became even easier when the screen could be purchased as a set of
pre-mixed solutions. The ﬁrst commercial instance of theJancarik and
Kim screen was the ‘Crystal Screen’ from Hampton Research,
available in 1991; this product is still available (product HR2-110).
Since then, effectively all crystallization campaigns start by screening
crystallization space using one or more of the hundreds of commer-
cially available (Newman et al., 2010) sparse matrix screens.
Many of the later sparse matrix screens have been developed by
cherry-picking successful conditions. For example, the JCSG+ screen
was derived from successful conditions obtained from a structural
genomics project on Thermotoga maritima (Page et al., 2003), and the
Morpheus screen was derived from conditions associated with
structures in the PDB (Gorrec, 2009). Are these second and third
generation sparse matrix screens a sensible reﬁnement of crystal-
lization space, or are they artefacts of the community’s oversampling
of a very limited number of points within a large crystallization space
by the over-enthusiastic adoption of commercial screens? The
structural biology community is certainly setting up many more
crystallization experiments now than ever before. But does this mean
the process of crystallization is now better or are we merely executing
an ill-deﬁned experiment more comprehensively? Certainly, the rate
of producing structures has gone up (PDB, http://www.wwpdb.org),
but is the improvement in efﬁciency a result of decreasing drop
volumes? How much of the increase can be simply attributed to more
people doing crystal structures? All these questions have been
discussed previously (Rupp & Wang, 2004).
The use of automation has signiﬁcantly increased the number of
crystallization experiments and their associated data; every year
there are literally millions of crystallization experiments being set up
in laboratories worldwide. Despite this, it is still the case that the only
data ever available externally from these efforts are the single crys-
tallization conditions associated with successfully characterized
structures, and often even these limited data are unavailable or
ambiguous (Peat et al., 2005; Tung & Gallagher, 2009). Other infor-
mation is recorded, but we discard the vast bulk of this data including
our experimental conditions and ﬁndings, so we cannot answer even
simple questions of provenance or effort required. Of course, these
data are not discarded wilfully, but only for lack of any effective use
for them.
With these thoughts in mind, the authors (representatives from
some of the larger public crystallization screening laboratories,
experts in chemical notation and databases as well as computational
scientists) came together in a small workshop in March 2011 led by
the Commonwealth Scientiﬁc and Industrial Research Organization
(CSIRO) in Canberra, Australia. The goal was to discuss ways that we
might capture, share and learn by using all the information available
from the vast number of crystallization experiments set up. In this
paper we report on this workshop, in particular a discussion on how
to capture crystallization experiments in a way that would help
improve the success of not only our own crystallization efforts but
also those of the community at large. We propose a crystallization
ontology for the community and provide our thoughts and rationale
leading to this conclusion. Our aim here is to bring this to the wider
audience of crystallographers so that they are aware of our early
efforts and can contribute to the process going forward.
2. Learning from ‘failure’
An experiment has only truly failed when it yields no information,
rather than when its outcome fails to realise our hopes. This is not
mere wordplay; this is the scientiﬁc method. However, in the high-
throughput crystallization world, a rather narrow deﬁnition of
‘success’ has been adopted: initial screens are deemed a success if a
crystal appeared; absence of crystals equates to ‘failure’. That we
have become content with extracting a mere binary read-out from a
set of hundreds of experiments, observed at multiple time-points as
feature-rich images, should give us pause for thought.
Certainly experiments that do not produce crystals can be very
informative. For instance, conditions that are not crystallization lead
conditions (conditions immediately judged worthy of optimization)
can guide us in determining where actual lead conditions are likely to
lie. Non-crystalline outcomes provide valuable solubility data
(Collins et al., 2005), and the crystallization screen can be an effective
method of understanding the phase behaviour of the sample (Snell et
al., 2008). Furthermore, information about the stability of the protein
can be gleaned from these data as well. Simply knowing how much
effort is normally required may guide decisions on when to move on
to a different protein construct.
We can estimate how much information we lose with a too-narrow
view of ‘failure’. The worldwide structural genomics efforts (where all
outcomes, crystallization and non-crystallization, are tracked) show
that out of 45K soluble, puriﬁed targets, 14K crystallized and 5K
resulted in a crystal structure (Berman et al., 2009). Another study, in
one of our crystallization centres [the Hauptman-Woodward Medical
Research Institute (HWI)], showed that a subset of 96 proteins
screened against a set of 1536 chemical cocktails gave 277 crystal
leads from 150K experiments. Although 36/96 of the proteins
produced one or more crystals, this equates to only 0.2% of the
experimental outcomes being crystals and 99.8% of the experi-
ments producing some other outcome (Snell et al., 2008).
The analysis above allows us to glimpse just how much data we are
discarding, since data collated from the structural genomics efforts
indicate the number of experiments associated with each structural
success. If we start with ten puriﬁed, soluble protein constructs, then
four are likely to crystallize, of which one is likely to produce a crystal
structure. In the screening process described above, these ten
proteins would be associated with 15 360 different crystallization
screening experiments. Our 1536-well experiments suggest that an
average of eight leads per sample are obtained when any individual
lead condition is seen. For 15 360 different experiments and ten
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outcomes, each of which adds more information on the protein’s
behaviour. Extrapolating this using the 5000 crystal structures
associated with structural genomics efforts, leads to an estimate of
about 80 million other outcomes that are not captured. If we extra-
polate it further to the whole PDB then the numbers become
astronomical.
Most laboratories do not screen 1536 different chemical conditions
in the initial search for lead conditions [for example the Collaborative
Crystallization Centre (C3), the Hamburg High-Throughput Crys-
tallization service (EMBL) and the Oxford Structural Genomics
Consortium (SGC) use 384, 576 and 576 conditions, respectively
1].
However, we have not counted any experiments associated with
subsequent optimization of protocols, and we use data from the
worldwide structural genomics efforts that may not represent the
practices of an individual laboratory, where years of effort and
experiments may be devoted to a particular project. Even if our
numbers are only a crude estimate (say, accurate to within an order of
magnitude), they demonstrate that we are missing data from tens to
hundreds of millions of experiments.
Clearly the combination of producing puriﬁed protein
2 and crys-
tallizing it is the major stumbling block in obtaining atomic resolution
coordinates of proteins. We contend that access to neglected data is
key to understanding the crystallization/protein production bottle-
neck, and furthermore that this requires a research effort beyond any
individual laboratory. Tools need to be set in place so that data can be
easily transferred, so we can avoid duplication of effort and achieve
the required critical mass of investigation. Furthermore, by analysing
data from a broad swath of laboratories we hope to capture many of
the possible experimental techniques and results, thus making the
output of such analyses widely applicable.
3. Attempts to data mine and improve crystallization
Consider the information provided by the analysis of limited crys-
tallization data. In a binary study, looking at crystal or no crystal,
Page et al. (2003) identiﬁed a minimal core screen. The Joint Center
for Structural Genomics (JCSG) reported 392 out of 465 proteins
(84%) required only 67 out of the 480 conditions sampled to yield a
crystal hit. Remarkably, for samples reported from the University of
Toronto (Kimber et al., 2003) six biochemical conditions produced
crystals for over half the proteins studied (180 out of 338). A simple
analysis of crystal versus no crystal data identiﬁed a subset of
conditions that, if used, had a high degree of success and could allow
the exploration of other factors, e.g. sample concentration, additives
etc. Interestingly a second paper from the same group (Collins et al.,
2005) explores the use of clear drops in determining buffers that may
be particularly suited to crystallization. This example demonstrates
that capturing data in a simple three-class system, i.e. crystal, clear,
something else, provides information that can help the crystallization
process. If we can expand this type of analysis to include a greater
number of biochemically diverse proteins, and pay careful attention
to bioinformatics associated with the sample, we can use this data to
gain signiﬁcant insight into the general process of crystallization.
Data on crystallization and subsequent X-ray diffraction from the
North East Structural Genomics group were analysed (Price et al.,
2009). The analysis compared crystals that resulted in structures with
bioinformatic and biophysical properties of the proteins. The data set
consisted of 697 strongly expressed well behaved proteins with one
construct for each protein target. These were screened to exclude
samples that were aggregated, samples with predicted transmem-
brane -helices or having greater than 20% low complexity
sequences. Some 157 of these yielded crystal structures with an
additional 39 yielding crystals that had insufﬁcient diffraction for
structural studies. The authors determined sequence speciﬁc features
that correlated with crystallization propensity. Similarly, an analysis
of data from the JCSG looked at protein production and crystal-
lization; a set of 1503 proteins that were successfully crystallized and
went on to reveal structural information were compared with 2456
that were not (Slabinski et al., 2007). The authors also determined
features that allowed an analysis of the potential for crystallization as
it related to general biophysical properties of the sample. Each of
these predictive mechanisms performs best when focused on the
sample subset it has been trained upon. Expanding beyond the
original data set to include more diverse samples requires analysis
and testing of a population representing those samples. Similarly,
expanding the capability will require expanded data. The authors
note that for enhanced analysis ‘more effort on data standardization
and exchange protocols is necessary’. An ontology approach achieves
these two requirements.
A number of studies have discussed the most effective sampling
strategy for crystallization. For example Segelke (2001) estimates that
288 trials are sufﬁcient to ﬁnd crystallization conditions with high
probability and the studies reported above show that success with 6
or 67 conditions is still remarkably high. Almost immediately the
reader should question the numbers we report: 384, 576 and 576
conditions with the extreme case being the HWI screening 1536
different chemical conditions (Luft et al., 2003; Luft, Snell et al., 2011)
We contend that screening at this level is useful. Sampling more
chemical space than that needed to ﬁnd a single lead condition
increases the probability of ﬁnding multiple conditions and provides
information to guide subsequent optimization. In the HWI case, this
was a deliberate design decision; the sampling of chemical space
identiﬁes not only crystallization conditions but also probes the
protein’s solubility. Rupp (2003), considering protein crystallization
as a sampling problem, noted that consistent data mining will be
difﬁcult because of inherent differences in the sampling of chemical
space for screening and optimization, and the variety of crystal-
lization methods employed. An ontology approach that takes these
differences into account and allows a collective global analysis of the
different crystallization practices in large centres and individual
laboratories will be much more powerful than an individual analysis
of experiments in a single centre.
4. Describing our attempts; measuring the outcomes
We identiﬁed two major, high-level challenges in achieving our
ambition to capture crystallization data: how to describe our attempts
to produce protein crystals; and how to measure the outcomes of
these attempts.
A description of our trials in some unambiguous, reproducible and
universally understood manner in principle requires nothing more
than a set of standards and a way of ensuring compliance to them. Yet
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1 The HWI, C3 and EMBL laboratories are services and will set up the
number of experiments requested by the customer. Details are available
at http://www.hwi.buffalo.edu/faculty_research/crystallization.html, http://
www.csiro.au/c3 and http://www.embl-hamburg.de/facilities/htpx/, respectively.
2 Of course, great strides have been made in producing target macromolecules
for positive crystallization results. The ability to clone speciﬁc genes and
manipulate them (via PCR) in the 1970s and 1980s made much of modern
crystallization possible. It may be that this area of endeavour might also
beneﬁt from an ontological analysis such as the one we propose.even this purely logistical, scientiﬁcally non-controversial task is very
challenging, as there are currently no deﬁned nomenclatures for
describing a crystallization experiment, not for the chemicals used,
nor for the physical parameters, never mind for the protein sample
itself. Take, for example, the non-protein component of a ‘standard’
(vapour diffusion or microbatch) crystallization experiment; this has
been called ‘the precipitant’, ‘the reservoir’, ‘the cocktail’, ‘the
condition’, ‘the well solution’ or (for the hopeful) ‘the crystallant’
amongst others. It has been reported that in the free-form data ﬁeld
for crystallization in the PDB (REMARK 280), the chemical
‘ammonium sulfate’ is represented by approximately 100 different
strings (Peat et al., 2005).
The problem of capturing outcomes objectively would appear even
more challenging still, as it requires scientiﬁc effort rather than
merely establishing conventions. At least the push into high-
throughput crystallization means that many recent experiments do
have a measured outcome, in the form of one or more image(s)
associated with the experiment. However, the image still has to be
translated objectively into a form that can be used for quantitative
analysis. This process will have to be automated to obtain not only
complete but also consistent results: manual scoring of the same
experiments is only about 70% consistent if using a seven-class
system (Walker et al., 2007).
The simplest outcome is the binary, crystal/no crystal classiﬁcation,
which can provide meaningful information. The other extreme is the
classiﬁcation of outcomes related to protein solubility and the phase
diagram, e.g. crystal, clear, precipitate, phase separation, skin etc.
(Luft, Wolﬂey et al., 2011) which provides for signiﬁcantly more
information. This is a more detailed classiﬁcation scheme, but
requires correspondingly higher analysis times and the data will be
less accurate than a simple binary classiﬁcation. It becomes increas-
ingly difﬁcult to differentiate between the classiﬁcations of similar-
looking outcomes when using a ﬁner granularity in the classiﬁcations.
Research in one of our centres (at HWI) has led to an automated
classiﬁer which is now comparable to humans at identifying single
categories such as clear, precipitate, and also combinations of phase,
skin, precipitate etc. but is not as precise or accurate when identifying
crystals (Kotseruba et al., 2012). Efforts to automate the classiﬁcation
of crystallization experimental outcomes have been ongoing for over
a decade (Pan et al., 2006; Cumbaa & Jurisica, 2005; Walker et al.,
2007). In designing our ontology we must keep in mind the reliability
of the measurement and its associated data. We have to capture not
only the outcome but how that outcome was determined. In this
manner we can account for different visual mechanisms (multiple
types of microscopes and magniﬁcations) and classiﬁcation schemes.
These will be aided by using other parts of the light spectrum, e.g.
ultraviolet, and even in situ X-ray analysis.
One of the results of the meeting was a commitment to develop a
vocabulary to capture the complete crystallization data available to
us. This vocabulary has several requirements. Overall it must be able
to capture any crystallization experiment; not only those from the
well deﬁned protocols of large-scale crystallization centres, but also
anything set up in less industrialized labs where scientists focus on
individual projects. Regardless of where a crystallization experiment
is performed, the information that needs to be captured is the same:
we want to know about the sample, the experiment and the outcome,
essentially the information captured in any good laboratory note-
book. However, it is useful to consider this information in the context
of what makes a difference to the experiment. Often seemingly small
changes in a protocol can have a dramatic impact on the experiment’s
outcome and reproducibility. Let us consider each of these three
categories in detail.
The sample can be described by a name and the sequence of the
protein,
3 or proteins, that comprise it. Important protein properties
may include sequence, molecular weight and isoelectric point
(Slabinski et al., 2007). The sample has other properties associated
with it: even a minimal sample consisting of only one protein in water
has an associated concentration, unit of concentration, a history (e.g.
‘snap frozen and thawed just prior to setup’). Preparation details of
the sample may be also be important, e.g. ‘retention time on a
column’, ‘purity’ and ‘polydispersity’.
3
The experimental setup, even for something as common as a
hanging-drop experiment (Benvenuti & Mangani, 2007), is also very
hard to describe precisely. Assuming ‘hanging drop’, we need to know
that is a type of ‘vapour diffusion’ and thus we should capture the
chemicals used, drop volumes, reservoir volume, initial concentra-
tions, predicted ﬁnal concentrations, the time course, surface areas,
geometry, material, incubation temperature, amongst other things.
Indeed, even the time between drop mixing and sealing (in vapour
diffusion), or the time course of temperature and dehydration can be
critical.
Outcomes, the results of our experiments, are a morass into which
we rarely delve with any enthusiasm: the sheer number of experi-
ments which we don’t accurately describe, or describe at all, attests to
this. To a large part this is a result of our ﬁxation, almost a glori-
ﬁcation, of crystals as the only useful result (Chayen & Saridakis,
2008). The non-crystal results can point toward an optimization
direction, although one may have to work harder to determine what
that direction is. There is a major difﬁculty in describing these non-
crystalline outcomes. When does a precipitate become an amorphous
or a crystalline precipitate? Is that drop clear, or is there evidence of a
light precipitate? Even then we should note we are looking at results,
and not reasons. Is that clear drop clear because it is under-saturated?
Is it clear because it is metastable? Or does it appear clear because
the perfect crystal contained within matches the refraction index of
the surrounding liquid and we simply cannot see it? We should not
only capture outcome, but also how that outcome was determined to
add a level of conﬁdence to the classiﬁcation. Was the classiﬁcation
strictly an evaluation through a low-magniﬁcation binocular micro-
scope, or were spectroscopic, UV ﬂuorescence, light scattering, dyes,
or other physico-chemical means employed for validation? One of
the potential beneﬁts of such rigour would be the development of
metrics to allow us to abandon non-productive experiments early.
This emphasises that our vocabulary has to be comprehensive, it
has to have multiple tiers to capture and integrate basic information
recorded in one laboratory with more detailed information from
another, and it has to be descriptive, precise and uniform.
A number of other disciplines have already faced these challenges
leading to the development of computational analysis techniques
built on ontologies (ﬁrst seen as the New Latin ontologia ‘the study of
that which is’). See for example Soldatova et al. (2006). An ontology
can be described as a structured formalization of knowledge that
reconciles different descriptions of similar things (Musen, 2007).
Ontology development deals with questions concerning the entities
of interest, and how they can be grouped, related to each other, and
subdivided according to similarities and differences. By developing a
common ontology, multiple different sets of data can be related to
each other via a common descriptive language. Given the ontology as
a basis, tools and methods of analysis developed for one set of data
can be shared and directly applied to data from other groups.
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3 The term ‘protein’ is used in this case to cover protein, nucleic acid and even
the carbohydrate and small-molecule components of an experiment.The ﬁeld of crystallography is not new to ontology developments.
Under the auspices of the International Union of Crystallography a
data exchange format was developed for small-molecule single-
crystal diffraction experiments, the Crystallographic Information File
(CIF) (Hall et al., 1991). An extension to this for macromolecules
(mmCIF) followed (Bourne et al., 1997). This includes some terms for
describing a successful crystal growth experiment but fewer for
describing the unsuccessful majority of outcomes in a crystallization
experiment. In developing a more detailed crystallization ontology,
we will be building on the current mmCIF with the aim of developing
a means to capture and be able to analyse all crystallization screening
experiments. To do so we have to comprehensively deﬁne the ‘things’
that it needs to represent. This includes both physical objects, e.g. in
the experiment example, ‘ammonium sulfate solution’, and the
properties associated with the object, e.g. ‘3.14 M concentration’,
‘contains NH4
+ ions’, ‘is volatile’, ‘has 2:1 stoichiometry of cations to
anions’. The power in the ontology approach comes from the ability
to use these descriptions and links between them (e.g. ‘all solutions
containing the cation NH4
+ are somewhat similar’) as the basis for
both describing our experiments and understanding better the rela-
tionships between experimental conditions and outcomes.
5. Using an ontology
The goal of our ontology is to develop a common language for
describing macromolecular crystallization experiments. We will
improve communication and progress when we have a common
nomenclature and universal descriptions that are shared by the
community to capture the essence of the crystallization process. Once
this is achieved, we have a common foundation to make all of our
individual experiments accessible to others in the ﬁeld. It is sobering
that despite the structural victories enabled by the high-throughput
technologies of the past decade, our means of sharing data is
predominately through publications. Currently, even among
seemingly similar crystallization platforms, we cannot move or readily
assimilate experimental data. Although many of the high-throughput
crystallization centres do analyse their own crystallization data,
producing, amongst other things, screens which are combinations of
experimentally derived hotspots of crystallization (Page et al., 2003;
Page & Stevens, 2004), these analyses are necessarily limited to the
data from that centre. Once we step outside any individual centre, the
best we can do in terms of data mining are rudimentary analyses of
the collective, single crystallization conditions reported for structural
determinations found in resources such as the PDB (Berman et al.,
2002, 2007), BMCD (Biological Macromolecular Crystallization
Database; Tung & Gallagher, 2009), or MPCD (Marseille Protein
Crystallization Database; Charles et al., 2006), amongst others. We
know of no other associated experimental details or results that are
routinely captured and shared amongst crystallization laboratories.
We need to develop a crystallization ontology to: enable a basic
ability to share our data; permit cross-centre analyses; and explore
the goal of learning from the non-crystalline outcomes that account
for 99.8% of our experiments. Without an ontology, it is not clear if
these goals can ever be realised. An immediate beneﬁt of an ontology
would be data standards which would help practitioners of crystal-
lization to unambiguously describe their crystallization experiments.
Thus, their results would be readily interpretable by other investi-
gators, a point appreciated by anyone who has struggled to reproduce
a crystal from published crystallization conditions.
We have commenced the task of building our ontology using
the World Wide Web Consortium’s (W3C, http://www.w3.org/
Consortium/) recommended Web Ontology Language, OWL. To
deﬁne the scope of our ontology, we have employed the method
proposed by Noy & McGuinness (2001) in which we design the
ontology to address certain ‘competency questions’, some of which
are shown below.
1. What was the outcome of this experiment (in qualitative terms)?
2. What were the methods used for this experiment?
3. What are the chemical and physical conditions of this experi-
ment?
4. What is the chemical or physical relationship between the
conditions of different experiments?
5. What observations relate to this experiment?
6. What sample was used for this experiment?
7. What was the intent of this batch of experiments?
Although there are a variety of tools available for developing
ontologies, our initial modest efforts use the Web Ontology Language
(OWL) for a number of reasons. It has the beneﬁt of being well
accepted; being highly structured, offering the advantages of both a
formal schema and a controlled vocabulary; and importantly, being
amenable to the representation of partial knowledge.
Currently, our ontology primarily comprises knowledge about
chemical crystallants; what needs expansion is how to capture char-
acteristics of proteins and constructs, experimental methods, condi-
tions, and outcomes. Much of our chemical knowledge has been
drawn from several pre-existing resources, including standard crys-
tallization reference books, the IUPAC Gold Book, ChEBI,
PubChem, and also incorporates dictionary terms published in the
IUCr Macromolecular CIF dictionary (mmCIF), as well as drawing
on our own unpublished knowledge of the ﬁeld. However, we
recognize that our initial attempt is incomplete, insufﬁciently docu-
mented, and is almost certainly at least partially incorrect.
One of the advantages of formalizing data in this manner is that we
can begin to test machine-learning techniques to mine the large body
of otherwise wasted experimental data. This will take time and a
collective effort from the community. We invite our readers to
contribute in the development of the ontology and invite them to
collaborate; please visit http://xdx-ontology.org to take part. The
eventual outcome will be to use the power of these massive quantities
of collected experimental data to guide the most efﬁcient crystal-
lization of a single sample.
6. Summary
Crystallization of biological macromolecules is seen by most struc-
tural biologists as a necessary evil, a means to the end, which is
knowledge about a biological system derived from a macromolecular
structure. Although the focus of biologists may be on structural
analysis to understand functional mechanisms, we argue that our
current knowledge about getting to that point may be insufﬁcient to
meet the challenges of the future. We currently throw away much of
the data that would otherwise enlighten us – not discarded lightly, but
for lack of any efﬁcient use for it. Without this option, to paraphrase
our opening quote, ‘we are condemned to repeat the past rather than
learning from it’. We believe that a concerted international effort
needs to be made to establish a common means to capture, share and
make use of this data. We hope that our initial efforts will help to start
this process.
We gratefully acknowledge the constructive criticism, help and
advice of Dr Howard Einspahr.
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